FCRL2: A Potential Drug Target and Biomarker (G79368)

Target Name: FCRL2

NCBI ID: G79368

FCRL2

FCRL2: A Potential Drug Target and Biomarker

FcR-like protein 2 (FCRL2) is a protein that is expressed in various tissues of the human body, including the liver, spleen, and kidney. It is a member of the FCRL family, which includes several other proteins that are involved in the immune response.FCRL2 has been identified as a potential drug target and biomarker due to its unique structure and the involvement of its protein activity in several diseases, including inflammation and fibrosis.

Structure and Function

FCRL2 is a type I transmembrane protein that consists of a single transmembrane domain and a cytoplasmic tail. It has a molecular weight of approximately 42 kDa and a pre-folds region that is involved in protein-protein interactions.FCRL2 is expressed in various tissues of the human body and has been shown to be involved in the immune response, inflammation, and fibrosis.

FCRL2 plays a crucial role in the regulation of inflammation and cellular responses to infection. It is a key regulator of the pro-inflammatory response and has been shown to play a role in the regulation of cytokine production and the expression of immune cells.FCRL2 has also been shown to be involved in the regulation of cell survival and has been linked to the development of several diseases, including cancer.

As a potential drug target, FCRL2 has been the focus of research at several institutions due to its unique structure and the potential impact of its protein activity on human health. Studies have shown that FCRL2 can be targeted by small molecules and antibodies, making it an attractive target for drug development.

FCRL2 as a Biomarker

In addition to its potential as a drug target, FCRL2 has also been identified as a potential biomarker for several diseases.FCRL2 has been shown to be involved in the regulation of inflammation and cellular responses to infection, making it an attractive target for biomarker development.

Studies have shown that FCRL2 levels are elevated in several diseases, including cancer, fibrosis, and inflammatory diseases. This suggests that FCRL2 may be a useful biomarker for these diseases and could be used to identify individuals at risk for these conditions.

FCRL2 has also been shown to be involved in the regulation of cellular processes that are important for human health, including wound healing and tissue regeneration. This suggests that FCRL2 may be a potential biomarker for several diseases, including wound healing disorders and tissue regeneration disorders.

Conclusion

In conclusion, FCRL2 is a protein that has the potential to be a drug target and biomarker. Its unique structure and involvement in the immune response and cellular processes make it an attractive target for drug development and biomarker development. Further research is needed to fully understand the role of FCRL2 in human health and to develop safe and effective treatments for diseases associated with its activity.

Protein Name: Fc Receptor Like 2

Functions: May have an regulatory role in normal and neoplastic B cell development

The "FCRL2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FCRL2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets